Editorial: Exploring endothelial injury syndromes: mechanisms, markers, and therapeutic potential
Panagiota Anyfanti, Christina Antza, Vasilios Kotsis

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAngiogenesis and VEGF in Cancer · Nitric Oxide and Endothelin Effects · Inflammation biomarkers and pathways
The field of endothelial injury syndromes has undergone a significant transformation in recent decades. Initially perceived as a simple anatomical structure, the endothelium is now recognized as a dynamic organ with multifaceted roles in maintaining physiological homeostasis. It is actively involved in regulating coagulation, vascular tone, permeability, and inflammatory responses. When the endothelium is activated, it can lose its integrity, leading to phenotypic changes that trigger procoagulant, pro-inflammatory, and pro-apoptotic mediators (1, 2). This dysfunction is central to a range of hematological conditions and other diseases, including cardiovascular, pulmonary, inflammatory, and tumoral disorders characterized by vascular injury (3–7). Despite the growing attention to endothelial injury syndromes, many questions remain unanswered. There is a need for further research to understand the mechanisms by which endothelial injury contributes to these disorders, develop robust markers for assessing the severity and progression of these syndromes, and explore the endothelium as a potential therapeutic target. Endothelial dysfunction may further serve as a valuable biomarker to guide personalized therapy by identifying patients who are more likely to benefit from targeted interventions.
This Research Topic aimed to explore the multifaceted roles of endothelial injury syndromes in hematology and beyond. Elucidating the mechanisms underlying endothelial injury in various vascular-related disorders will promote the identification and development of endothelial markers for assessing the severity and progression of these syndromes, and ultimately, facilitate the utilization of the endothelium as a therapeutic target. By addressing these objectives, research collected in this Research Topic seeks to advance our understanding of endothelial dysfunction and its implications across different medical specialties. All submitted articles underwent a rigorous peer-review process. Ultimately, ten articles were published.
This interdisciplinary approach encourages collaboration among basic, translational, and clinical researchers from various specialties, including hematology, cardiology, inflammatory and infectious diseases, nephrology, oncology, and transplantation, to facilitate the exchange of new concepts and update state-of-the-art knowledge regarding mechanisms, markers, and therapeutic potential of endothelial injury syndromes.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Gavriilaki E Anyfanti P. Editorial: endotheliopathies: current concepts and importance in clinical practice. Front Med. (2023) 10:1162121. 10.3389/fmed.2023.116212136936244 PMC 10022819 · doi ↗ · pubmed ↗
- 2Battistoni A Dimitroulas T Anyfanti P. Editorial: Vascular injury in systemic diseases: current concepts and future perspectives. Front Cardiovasc Med. (2025) 12:1656542. 10.3389/fcvm.2025.165654240761229 PMC 12318722 · doi ↗ · pubmed ↗
- 3Anyfanti P Margouta A Goulas K Gavriilaki M Lazaridou E Patsatsi A. Endothelial dysfunction in psoriasis: an updated review. Front Med. (2022) 9:864185. 10.3389/fmed.2022.86418535755028 PMC 9226899 · doi ↗ · pubmed ↗
- 4Anyfanti P Gavriilaki E Douma S Gkaliagkousi E. Endothelial dysfunction in patients with rheumatoid arthritis: the role of hypertension. Curr Hypertens Rep. (2020) 22:56. 10.1007/s 11906-020-01064-y 32671677 · doi ↗ · pubmed ↗
- 5Gavriilaki E Anyfanti P Gavriilaki M Lazaridis A Douma S Gkaliagkousi E. Endothelial dysfunction in COVID-19: lessons learned from coronaviruses. Curr Hypertens Rep. (2020) 22:63. 10.1007/s 11906-020-01078-632852642 PMC 7449866 · doi ↗ · pubmed ↗
- 6Lamprou S Koletsos N Mintziori G Anyfanti P Trakatelli C Kotsis V. Microvascular and endothelial dysfunction in prediabetes. Life. (2023) 13:644. 10.3390/life 1303064436983800 PMC 10057153 · doi ↗ · pubmed ↗
- 7Naderi-Meshkin H Setyaningsih WAW. Endothelial cell dysfunction: onset, progression, and consequences. Front Biosci. (2024) 29:223. 10.31083/j.fbl 290622338940049 · doi ↗ · pubmed ↗
